ArticleFrontiers in oncology2020

LIMD1 Increases the Sensitivity of Lung Adenocarcinoma Cells to Cisplatin via the GADD45α/p38 MAPK Signaling Pathway.

Xiaofei Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.